A rapid and highly diastereoselective synthesis of enantiomerically pure (4R,5R)- and (4S,5S)-isocytoxazone by Benjamin Buckley (1249668) et al.
 
 
 
This item was submitted to Loughborough’s Institutional Repository 
(https://dspace.lboro.ac.uk/) by the author and is made available under the 
following Creative Commons Licence conditions. 
 
 
 
 
 
For the full text of this licence, please go to: 
http://creativecommons.org/licenses/by-nc-nd/2.5/ 
 
1 LETTER  
Template for SYNLETT and SYNTHESIS © Thieme  Stuttgart · New York 2011-02-25 page 1 of 5 
Abstract: A three step protocol for the highly diasteroselective 
(>98%) synthesis of both (4R,5R)- and (4S,5S)- iso-cytoxazone 
from (D)- or (L)- tyrosine is reported. The diasteroselection was 
confirmed by X-ray crystallography. This synthesis is currently 
the highest yielding approach towards these enantiomerically pure 
biologically active oxazolidinones  
Key words: Diastereoselective, Cytoxazone, Tyrosine, Oxazolidi-
none, Oxidation. 
During the course of screening for chemical 
immunomoderators from microbial metabolites, Osada 
found that an actinomycete strain (RK95-31) produced 
cytoxazone 1, an oxazolidinone that interferes with 
cytokine IL-4, IL-10 and IgG production.1 Several groups 
have synthesized (–)-cytoxazone 1 and (+)-epi-cytoxazone 
2,2 and Šunjic has described the racemic syntheses of all of 
the stereoisomers and cogeners of iso-cytoxazone 3; 
enantiomerically pure samples were isolated by preparative 
HPLC.3 A theoretical study on the absolute configurations 
of 1 and 3 has been carried out by Berova, as have 
extensive X-ray crystallographic studies.4 
Rozwadowska and Tomczak have recently reported the 
synthesis of (4S,5S)-(–)-iso-cytoxazone 3,5 but the synthesis 
required seven synthetic steps, the last of which afforded a 
mixture of regioisomers in an overall yield of 8.1%. 
Prompted by these studies after reporting several routes to 
1,3 amino diols6 we herein report our efforts in this area, 
utilizing a rapid highly diasteroselective three-step process 
from Boc-protected D- or L- tyrosine. 
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Figure 1 The cytoxazones 
Our original strategy towards (4S,5S)-iso-cytoxazone was 
similar to that of Rozwadowska, using diazotization as a 
key reaction step (Scheme 1). 
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Scheme 1 Retrosynthetic route towards (4S,5S)-iso-isocytoxazone 
Hydrogenation of the nitro group in the formate-protected 
amino diol 4 to give the corresponding amino compound 5 
proved highly successful (99% yield). The subsequent diazoti-
zation reaction, however, was extremely poor, giving at best 
15% yield in our hands (the reaction has previously been re-
ported to give yields of up to 35%7). Further manipulation of 
product 6 afforded the 4-hydroxyphenyl-1,3-dioxane 7. Methy-
lation, after some experimentation, was achieved with caesium 
carbonate and dimethyl sulfate, producing the 4-
methoxyformate 8, but separation from by-products brought 
through from the initial diazotization reaction proved difficult 
(Scheme 2). Before this approach was abandoned, an interest-
ing reaction reported by Quin and Macdiarmid was attempted, 
whereby direct conversion from an amine group to a methoxy 
group is possible using iso-amyl nitrite in methanol (Scheme 
3).8 Unfortunately, when using our substrate, this led to a com-
plex mixture of products, including loss of the formate protect-
ing group.  
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Reagents and Conditions: i: H2/Pd, ethanol, r.t. 24 h, 99 %; ii: a) 
NaNO2, H2SO4, b) pH 6, ∆, 15 %; iii, 2,2-DMP, acetone, CSA, 
r.t., 4 h, 72 %; iv: Cs2CO3, Me2SO4, CH2Cl2, 48 h, 72 %. 
Scheme 2 Initial synthesis of the p-methoxy formate 8. 
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Reagents and Conditions: i: a) H2SO4, MeOH, 
(CH3)2CHCH2CH2ONO, 0 ºC, 3 h; b) ∆, 1 h. 
Scheme 3 Attempted direct incorporation of the methoxy group using 
Quin and Macdiarmid’s method. 
We next reasoned that (4S,5S)-iso-cytoxazone 3 could be 
prepared from commercially available Boc-(D)-tyrosine 
(Scheme 4).  
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Scheme 4 A revised retrosynthetic route towards (4S,5S)-iso-
isocytoxazone from Boc-D-tyrosine 
We initially aimed to prepare the enantiomer of 3 
(4R,5R)-iso-cytoxazone ent-3 from the cheaper Boc-(L)-
tyrosine (Schemes 5, 6 and 7). Methylation of the acid and 
phenol components within Boc-(L)-tyrosine with potassium 
hydroxide and iodomethane afforded 10,9 the required pre-
cursor to 11.  
O HN
O
O
O
O
HO NHBoc
OH
O
i
9 10
 
Reagents and Conditions: i: MeI (2.2 eq.), KOH (2.2 eq.), DMF, 0 
ºC-r.t. 3.5 h, 74 %. 
Scheme 5 Formation of Boc-protected, dimethylated (L)-tyrosine 10. 
Following the work of Ohfune,10 the benzylic position of 10 
was oxidized with potassium persulfate (K2S2O8) and catalytic 
copper sulfate to form the oxazolidinone 1111 in a highly di-
astereoselective manner (diastereomeric ratio ≥ 98 % R at C3) 
(Scheme 6).  
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Reagents and Conditions: K2S2O8, CuSO4, H2O/MeCN (1:1), 70 
°C, 3h, 52%. 
Scheme 6 Ohfune’s cyclic carbamate formation. 
The authors suggest that this high selectivity in cyclic 
carbamate formation arises because the reaction proceeds 
via the more stable conformer of benzyl cation intermediate 
10b. The conformer 10a is more strained than 10b due to 
steric interaction between the ester group and the ortho 
hydrogen atom. Intramolecular trapping of this cation by a 
carboxyl oxygen and subsequent release of the tert-butyl 
cation, which is believed to be more stable than the ben-
zylic cation of 10, is thought to be a driving force for the 
reaction. This was supported by Ohfune’s observation that 
only poor yields were obtained from compounds containing 
other amino protecting groups, such as the Cbz group. Con-
firmation of the stereoselectivity was achieved from the X-
ray crystal structure of compound 11, as shown in Figure 2. 
 
Figure 2 X-ray crystal structure of 1112 
Although this reaction is highly stereoselective, some 
problems were encountered during the synthesis. Yields 
tended to vary on scale-up of the reaction. Initially, the 
reaction on 4 mmol of substrate afforded 50% of the de-
sired product (a good yield given the reported yield of 
55%), but on increasing the scale to 26 mmol a drop in 
yield to 40% was observed. Optimum conditions were 
found when carrying the reaction out on a 16 mmol scale - 
a 52 % yield of product was obtained. Attempts to drive the 
reaction to completion proved fruitless. Generally, in-
creased reaction times and temperatures decreased the 
overall yield due to generation of higher levels of the side 
product 4-methoxy benzaldehyde (a product of over-
oxidation).10 Milder reaction conditions resulted in no prod-
uct formation.  
 
In order to afford the desired (4R,5R)-iso-cytoxazone ent-
313 the carbamate 11 was then reduced; this was initially 
achieved with lithium aluminium hydride, but sodium 
borohydride provided a superior yield (91 % compared to 
77 %), probably due to the ease of work-up associated with 
the sodium borohydride reactions, (Scheme 7). (4S,5S)-Iso-
cytoxazone 3 was prepared by repeating this optimized 
sequence using (D)-tyrosine as the starting material, in an 
overall yield of 33%.14  
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Reagents and Conditions: i: NaBH4, EtOH, 0 °C to r.t. 45 min, 
91%. 
Scheme 1 Formation of (4R,5R)-iso-cytoxazone ent-3. 
In conclusion we have reported here the highly di-
asteroselective synthesis of (4R,5R)-iso-cytoxazone ent-3 
and (4S,5S)-iso-cytoxazone 3 in just three synthetic steps 
from (D)- or (L)- Boc-tyrosine, and confirmation of the 
stereoselection by X-ray crystallography. This is the short-
est and most high yielding approach (35% overall yield 
compared to 8.1% overall yield reported previously) cur-
rently known for this class of biologically active oxazolidi-
nones. 
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